OMICS Journal of Radiology
Open Access

Pediatric extra-cranial tumors, also known as pediatric solid tumors, are a diverse group of neoplasms that occur outside the central nervous system in children and adolescents. These tumors can arise from various tissues, including soft tissues, bones, muscles, and organs, presenting unique challenges in diagnosis and treatment. Medical imaging plays a pivotal role in the identification, characterization, and management of these tumors, enabling early detection and informed decision-making for optimal patient outcomes [1].

Types of pediatric extra-cranial tumors

Pediatric extra-cranial tumors encompass a wide array of malignancies, each with distinct characteristics, behavior and therapeutic considerations. Common types include:

Neuro blastoma: A cancer that arises from developing nerve cells and is most commonly found in the adrenal glands (located on top of the kidneys). It often presents with abdominal masses and can metastasize widely.

Wilms tumor: This is a kidney tumor, also known as nephroblastoma, frequently diagnosed in early childhood. It usually presents as a palpable abdominal mass.

Rhabdomyosarcoma: Originating from skeletal muscle progenitor cells, this tumor is found in various locations including the head and neck region, genitourinary tract, and extremities [2].

Osteosarcoma: The most common type of bone cancer in children and adolescents, typically originating in long bones such as the arms and legs.

Ewing sarcoma: A highly malignant tumor that often arises in bones and soft tissues, presenting with localized pain and swelling.

Hepato blastoma: A rare tumor occurring in the liver, mainly affecting infants and young children. It usually presents with an abdominal mass and other symptoms.

Description

Role of imaging in diagnosis and staging

Accurate diagnosis and staging of pediatric extra-cranial tumors are crucial for determining the extent of disease, planning treatment strategies, and assessing prognosis. Various imaging modalities are employed, depending on the suspected tumor type and location:

Ultrasound: Often used as the initial imaging modality, ultrasound is non-invasive and helps visualize abdominal and soft tissue masses, providing valuable information about tumor size, location, and vascularity [3].

Computed tomography (CT): CT scans provide detailed crosssectional images of the body and are particularly useful for evaluating bony tumors, lung metastases, and assessing lymph node involvement.

Magnetic resonance imaging (MRI): MRI offers excellent soft tissue contrast and is crucial for characterizing the extent of soft tissue tumors, as well as assessing involvement of adjacent structures.

Positron emission tomography (PET): PET scans, combined with CT (PET-CT), provide functional information by detecting areas of increased metabolic activity. This is valuable for assessing tumor activity, identifying metastases, and monitoring treatment response.

Bone scans: These scans, using radiolabeled tracers, help identify areas of bone involvement and metastasis in conditions like osteosarcoma and Ewing sarcoma [4].

Challenges and advances

Diagnosing pediatric extra-cranial tumors can be challenging due to their variable presentation and the need to differentiate them from benign conditions. Moreover, the use of ionizing radiation in certain imaging modalities, such as CT scans, raises concerns about long-term effects, especially in pediatric patients. As a result, efforts are ongoing to minimize radiation exposure through techniques like low-dose protocols and judicious imaging utilization [5].

Recent advances in imaging technology have significantly improved our ability to diagnose and manage pediatric extra-cranial tumors. Techniques like diffusion-weighted imaging (DWI) in MRI and molecular imaging have enhanced our ability to differentiate tumor tissue from normal tissue and assess treatment response accurately. Additionally, the integration of multi-modal imaging approaches, such as combining MRI and PET-CT, offers a comprehensive view of the disease’s extent and characteristics.

Radiation concerns and alternative imaging modalities

While imaging is crucial for the diagnosis and management of pediatric extra-cranial tumors, there is a growing emphasis on minimizing radiation exposure, especially in young patients who are more sensitive to the harmful effects of ionizing radiation. This concern has led to the development and utilization of alternative imaging modalities that do not involve ionizing radiation:

Magnetic resonance imaging (MRI): MRI is a radiation-free imaging technique that uses strong magnetic fields and radio waves to generate detailed images of the body’s internal structures. It is particularly valuable for soft tissue visualization and is commonly used to assess the extent of soft tissue tumors, such as rhabdomyosarcoma, which often occur in the head and neck region.

Ultrasound: Ultrasound is another radiation-free imaging modality that uses sound waves to create images of internal organs and tissues. It is frequently used for initial evaluations and follow-up assessments of pediatric tumors. Ultrasound is safe, non-invasive, and well-suited for monitoring tumor response to treatment.

Functional MRI (FMRI): This specialized form of MRI provides information about brain activity by measuring changes in blood flow. While commonly used in neurological studies, fMRI is also being explored for its potential in evaluating certain brain tumors.

Contrast-enhanced ultrasound (CEUS): This technique involves the injection of contrast agents to enhance the visibility of blood vessels and tissues during ultrasound imaging. CEUS can provide valuable information about the vascularity of tumors and aid in their characterization.

Functional imaging techniques: Techniques like diffusionweighted imaging (DWI) in MRI and dynamic contrast-enhanced MRI (DCE-MRI) offer insights into tissue characteristics, perfusion, and cellularity, aiding in tumor characterization and treatment planning.

Image-guided interventions

Image-guided interventions have revolutionized the management of pediatric extra-cranial tumors by allowing minimally invasive procedures to be performed with precision. These interventions can include:

Biopsy: Image-guided biopsies involve the use of imaging techniques such as ultrasound, CT, or MRI to guide the placement of a needle or other instrument into the tumor for tissue sampling. This provides essential information for accurate diagnosis and treatment planning.

Ablation: Techniques like radiofrequency ablation (RFA) and cryoablation involve using imaging guidance to target and destroy tumor tissue with heat or cold. These methods are particularly useful for treating small, localized tumors [6].

Tumor embolization: This procedure involves using imaging guidance to introduce materials into blood vessels to block or reduce blood flow to tumors. It is often used to shrink tumors before surgical removal or to control bleeding.

Advances in image analysis and artificial intelligence

The field of pediatric oncology is benefitting from the integration of advanced image analysis techniques and artificial intelligence (AI). AI algorithms can assist radiologists in detecting, characterizing, and quantifying tumors more accurately and efficiently. These tools can also aid in monitoring treatment response and predicting outcomes based on imaging data [7].

Conclusion

Imaging remains an indispensable tool in the diagnosis, staging, and treatment of pediatric extra-cranial tumors. As medical technology continues to evolve, the emphasis on reducing radiation exposure while maintaining diagnostic accuracy is paramount. Non-ionizing radiation techniques like MRI and ultrasound, coupled with image-guided interventions and AI-driven analyses, are driving advancements that enhance our ability to diagnose these tumors early, guide treatment decisions, and ultimately improve the lives of young patients facing the challenges of cancer.

Acknowledgement

None

Conflict of Interest

None

1. Bhujwalla ZM, Artemov D, Glockner J (1999) Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. Top Magn Reson Imaging 10: 92-103.

Indexed at, Google Scholar, Crossref

2. Padhani AR (1999) Dynamic contrast-enhanced MRI studies in human tumours. Br J Radio 72: 427-431.

Indexed at, Google Scholar, Crossref

3. Weidner N (1996) Intratumoural vascularity as a prognostic factor in cancers of the urogenital tract. Eur J Cancer 32A: 2506-2512.

Indexed at, Google Scholar, Crossref

4. Hong CR, Kang HJ, Ju HY, Lee JW, Kim H, et al. (2015) Extra-cranial Malignant Rhabdoid Tumor in Children: A Single Institute Experience. Cancer Res Treat 47: 889-896.

Indexed at, Google Scholar, Crossref

5. Katsumi Y, Iehara T, Kuwahara Y, Tsuchiya K, Konishi E, et al. (2022) Diverse outcomes in extra-cranial rhabdoid tumors: A single institute experience. Pediatr Hematol Oncol 39: 278-285.

Indexed at, Google Scholar, Crossref

6. Mora J (2016) Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma. Expert Rev Clin Pharmacol. Expert Rev Clin Pharmacol 9: 647-653.

Indexed at, Google Scholar, Crossref

7. Schmidt M, Baum RP, Simon T, Howman-Giles R (2010) Therapeutic nuclear medicine in pediatric malignancy. Q J Nucl Med Mol Imaging 54: 411-428.

Indexed at, Google Scholar